Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now

Published:2017-05-02 Issue:8 Volume:34 Page:1551-1555
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Weitzel Kristin W.,Cavallari Larisa H.,Lesko Lawrence J.

Funder

National Human Genome Research Institute

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/article/10.1007/s11095-017-2163-x/fulltext.html

Reference20 articles.

1. Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526(7573):343–50. doi: 10.1038/nature15817 .

2. Van Driest SL, Shi Y, Bowton EA, Shildcrout JS, Peterson JF, Pulley J, et al. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther. 2014;95(4):423–31. doi: 10.1038/clpt.2013.229 .

3. Bell GC, Crews KR, Wilkinson MR, Haidar CE, Hicks JK, Baker DK, et al. Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc. 2014;21(e1):e93–9. doi: 10.1136/amiajnl-2013-001993 .

4. Schildcrout JS, Denny JC, Bowton E, Gregg W, Pulley JM, Basford MA, Cowan JD, Xu H, Ramirez AH, Crawford DC, Ritchie MD, Peterson JF, Masys DR, Wilke RA, Roden DM. Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. Clin Pharmacol Ther. 2012;92(2):235–42. doi: 10.1038/clpt.2012.66 .

5. Dunnenberger HM, Crews KR, Hoffman JM, Caudle KE, Broeckel U, Howard SC, et al. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol. 2015;55:89–106. doi: 10.1146/annurev-pharmtox-010814-124835 .

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review;Pharmacogenomics;2024-09-04

2. Strategy and technologies of distribution and implementation of pharmacogenomics in clinical practice: foreign experience;Pharmacogenetics and Pharmacogenomics;2024-06-18

3. Estimating the prevalence of potential and actionable drug‐gene interactions in Irish primary care: A cross‐sectional study;British Journal of Clinical Pharmacology;2024-06-12

4. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology;Journal of Clinical Oncology;2024-04-01

5. Estimation of the benefit from pre‐emptive genotyping based on the nationwide cohort data in South Korea;Clinical and Translational Science;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3